Summit Therapeutics, Inc. (SMMT)
15.94
+0.07
(+0.44%)
USD |
NASDAQ |
Feb 20, 16:00
15.74
-0.20
(-1.25%)
After-Hours: 20:00
Summit Therapeutics Shareholders Equity (Quarterly) : 192.26M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Exelixis, Inc. | 2.161B |
| Insmed, Inc. | 738.98M |
| Madrigal Pharmaceuticals, Inc. | 602.69M |
| Soleno Therapeutics, Inc. | 494.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 261.73M |
| Total Liabilities (Quarterly) | 69.47M |
| Debt to Equity Ratio | 0.0282 |
| Current Ratio | 3.796 |
| Net Debt Paydown Yield | 0.13% |